Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
Sadegh Saghafinia, Marco Mina, Nicolò Riggi, et al.
Cell Reports (2018) Vol. 25, Iss. 4, pp. 1066-1080.e8
Open Access | Times Cited: 308

Showing 1-25 of 308 citing articles:

Hallmarks of Cancer: New Dimensions
Douglas Hanahan
Cancer Discovery (2022) Vol. 12, Iss. 1, pp. 31-46
Open Access | Times Cited: 3308
Navigating the DNA methylation landscape of cancer
Atsuya Nishiyama, Makoto Nakanishi
Trends in Genetics (2021) Vol. 37, Iss. 11, pp. 1012-1027
Open Access | Times Cited: 622
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf, Anamaria Brozović, Ana Cristina Gonçalves, et al.
Drug Resistance Updates (2019) Vol. 46, pp. 100645-100645
Closed Access | Times Cited: 438
The DNA methylation landscape of advanced prostate cancer
Shuang G. Zhao, William S. Chen, Haolong Li, et al.
Nature Genetics (2020) Vol. 52, Iss. 8, pp. 778-789
Open Access | Times Cited: 280
Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K‐Akt signaling in gastric cancer
Cheng Zhang, Mengqi Zhang, Sai Ge, et al.
Cancer Medicine (2019) Vol. 8, Iss. 10, pp. 4766-4781
Open Access | Times Cited: 227
Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability
Wa Zhang, David Klinkebiel, Carter J. Barger, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 764-764
Open Access | Times Cited: 223
Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer
William M. Grady, Ming Yu, Sanford D. Markowitz
Gastroenterology (2020) Vol. 160, Iss. 3, pp. 690-709
Open Access | Times Cited: 172
Pan-cancer proteogenomics connects oncogenic drivers to functional states
Yize Li, Eduard Porta‐Pardo, Collin Tokheim, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3921-3944.e25
Open Access | Times Cited: 55
Cancer aneuploidies are shaped primarily by effects on tumour fitness
Juliann Shih, Shahab Sarmashghi, Nadja Zhakula-Kostadinova, et al.
Nature (2023) Vol. 619, Iss. 7971, pp. 793-800
Open Access | Times Cited: 50
Multitarget Stool RNA Test for Colorectal Cancer Screening
Erica K. Barnell, Elizabeth M. Wurtzler, Julie La Rocca, et al.
JAMA (2023) Vol. 330, Iss. 18, pp. 1760-1760
Open Access | Times Cited: 47
Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy
Simona Migliozzi, Young Taek Oh, Mohammad Hasanain, et al.
Nature Cancer (2023) Vol. 4, Iss. 2, pp. 181-202
Open Access | Times Cited: 42
Multi‐omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple‐negative breast cancer
Jindong Xie, Xinpei Deng, Yi Xie, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 32
The role of aberrant DNA methylation in cancer initiation and clinical impacts
Franziska Geissler, Ksenija Nesic, Olga Kondrashova, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 20
Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
Xing Hua, Zhao Wei, Angela Cecilia Pesatori, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 101
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING
Marine Bruand, David Barras, Marco Mina, et al.
Cell Reports (2021) Vol. 36, Iss. 3, pp. 109412-109412
Open Access | Times Cited: 90
Genome-wide methylation patterns predict clinical benefit of immunotherapy in lung cancer
Jeong Yeon Kim, Jung Kyoon Choi, Hyunchul Jung
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 81
Advances in epigenetic therapeutics with focus on solid tumors
Ning Jin, Tiffany L. George, Gregory A. Otterson, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 81
Dietary antioxidants remodel DNA methylation patterns in chronic disease
Megan Beetch, Sadaf Harandi‐Zadeh, Kate Shen, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 6, pp. 1382-1408
Open Access | Times Cited: 77
KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview
Joanna Sobocińska, Sara Molenda, Marta Machnik, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2212-2212
Open Access | Times Cited: 68
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
Xin Hu, Marcos R. Estecio, Runzhe Chen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 60
DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation
R.N. Batra, Aviezer Lifshitz, Ana Tufegdžić Vidaković, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 60
Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer
Miaomiao Huo, Jingyao Zhang, Wei Huang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 60
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors
Sujun Chen, Jessica Petricca, Wenbin Ye, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Recent Advances and Emerging Trends in Cancer Biomarker Detection Technologies
R. K. Rakesh Kumar, Amit Kumar, Cheng-Hsin Chuang, et al.
Industrial & Engineering Chemistry Research (2023) Vol. 62, Iss. 14, pp. 5691-5713
Closed Access | Times Cited: 37
Epigenetic reprogramming in cancer: From diagnosis to treatment
Pedro M. S. Costa, Sarah Leyenne Alves Sales, Daniel Pascoalino Pinheiro, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top